Home » Stocks » AOLS

Aeolus Pharmaceuticals Inc. (AOLS)

Stock Price: $0.0040 USD -0.0001 (-2.44%)
Updated Jul 28, 2021 2:38 PM EDT - Market open
Market Cap 532,301
Revenue (ttm) 771,000
Net Income (ttm) -4.09M
Shares Out 152.09M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 28
Last Price $0.0040
Previous Close $0.0041
Change ($) -0.0001
Change (%) -2.44%
Day's Open 0.0030
Day's Range 0.0040 - 0.0040
Day's Volume 65,457
52-Week Range 0.0010 - 0.0200

News

There are no news available yet.

About AOLS

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which ... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Feb 1, 1996
CEO
John McManus
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
AOLS
Full Company Profile

Financial Performance

In 2016, AOLS's revenue was $2.08 million, a decrease of -33.27% compared to the previous year's $3.11 million. Losses were -$3.56 million, 35.4% more than in 2015.

Financial Statements